Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia

Abstract Controversial results concerning insulin resistance and lipid metabolism have been reported in antipsychotic-naive first-episode psychosis (AN-FEP) patients with schizophrenia of different countries. We aimed at determining whether schizophrenia-related psychopathology was associated with i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychiatry research 2013-12, Vol.210 (3), p.825-829
Hauptverfasser: Chen, Song, Broqueres-You, Dong, Yang, Guigang, Wang, Zhiren, Li, Yanli, Wang, Ning, Zhang, Xiangyang, Yang, Fude, Tan, Yunlong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 829
container_issue 3
container_start_page 825
container_title Psychiatry research
container_volume 210
creator Chen, Song
Broqueres-You, Dong
Yang, Guigang
Wang, Zhiren
Li, Yanli
Wang, Ning
Zhang, Xiangyang
Yang, Fude
Tan, Yunlong
description Abstract Controversial results concerning insulin resistance and lipid metabolism have been reported in antipsychotic-naive first-episode psychosis (AN-FEP) patients with schizophrenia of different countries. We aimed at determining whether schizophrenia-related psychopathology was associated with insulin resistance and/or dyslipidaemia in Chinese patients with AN-FEP schizophrenia. A cross-sectional study was performed in Chinese patients newly diagnosed with schizophrenia ( n = 49, antipsychotic-naïve or antipsychotic medications< 2 weeks) and healthy volunteers ( n = 30). The serum levels of insulin and triglyceride levels as well as homeostasis model of assessment-insulin resistance (HOMA-IR) index were significantly increased in AN-FEP patients, when compared with healthy volunteers. The gender difference had a significant impact on the insulin resistance and dyslipidaemia in these AN-FEP subjects. Multiple linear regression analysis demonstrated that the severity of positive symptoms of schizophrenia was negatively related to insulin resistance. No difference of serum glucose level, total cholesterol content, body mass index (BMI) and smoking status was detected between patients with schizophrenia and healthy controls. In conclusion, Chinese AN-FEP patients were more prone to insulin resistance and dyslipidaemia as compared to the healthy population, which is negatively correlated to positive symptoms. The results may contribute to the understanding of the relationship between the glucose/lipidaemia metabolic dysfunction and the psychopathology in patients with schizophrenia.
doi_str_mv 10.1016/j.psychres.2013.08.056
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1461881003</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0165178113005179</els_id><sourcerecordid>1461881003</sourcerecordid><originalsourceid>FETCH-LOGICAL-c453t-918da8a19a92edd8ddb4a0e9ecf6e8d625a2407d394e5d6e9b7533523d7d61f93</originalsourceid><addsrcrecordid>eNqFktuKFDEQhhtR3HH1FZbcCF7YYw59yo0ogydYEDxch0xSzdTYnbRdmV3a5_CBzTizCt4IgQTqq0P-v4riSvC14KJ5sV9PtLjdDLSWXKg179a8bu4VK9G1smyFVPeLVQbrUrSduCgeEe0551Jo_bC4kJUQSki5Kn5-gsEmjIF2OLEtpFuAwDDQYcDAcnmkZIOD58wvNOCE3sKIltng2RQJE94Ao2WcUhxzGtvsMABBjif8PWFM6Mpgj1iPM6USJqTogU25LYRE7BbTjpHb4Y845Q8FtI-LB70dCJ6c78vi69s3Xzbvy-uP7z5sXl-XrqpVKrXovO2s0FZL8L7zfltZDhpc30DnG1lbWfHWK11B7RvQ27ZWqpbKt74RvVaXxbNT3WmO3w9AyYxIDobBBogHMqJqRNcJzlVGmxPq5kg0Q2-mGUc7L0Zwc3TE7M2dI-boiOGdyY7kxKtzj8N2BP8n7c6CDDw9A5acHfo5y430l-t4Pppn7tWJg6zIDcJsyGUBHXicwSXjI_5_lpf_lHDZZcxdv8ECtI-HOWS9jTAkDTefj_tzXB-hOM8PrX4B1wjHXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1461881003</pqid></control><display><type>article</type><title>Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Chen, Song ; Broqueres-You, Dong ; Yang, Guigang ; Wang, Zhiren ; Li, Yanli ; Wang, Ning ; Zhang, Xiangyang ; Yang, Fude ; Tan, Yunlong</creator><creatorcontrib>Chen, Song ; Broqueres-You, Dong ; Yang, Guigang ; Wang, Zhiren ; Li, Yanli ; Wang, Ning ; Zhang, Xiangyang ; Yang, Fude ; Tan, Yunlong</creatorcontrib><description>Abstract Controversial results concerning insulin resistance and lipid metabolism have been reported in antipsychotic-naive first-episode psychosis (AN-FEP) patients with schizophrenia of different countries. We aimed at determining whether schizophrenia-related psychopathology was associated with insulin resistance and/or dyslipidaemia in Chinese patients with AN-FEP schizophrenia. A cross-sectional study was performed in Chinese patients newly diagnosed with schizophrenia ( n = 49, antipsychotic-naïve or antipsychotic medications&lt; 2 weeks) and healthy volunteers ( n = 30). The serum levels of insulin and triglyceride levels as well as homeostasis model of assessment-insulin resistance (HOMA-IR) index were significantly increased in AN-FEP patients, when compared with healthy volunteers. The gender difference had a significant impact on the insulin resistance and dyslipidaemia in these AN-FEP subjects. Multiple linear regression analysis demonstrated that the severity of positive symptoms of schizophrenia was negatively related to insulin resistance. No difference of serum glucose level, total cholesterol content, body mass index (BMI) and smoking status was detected between patients with schizophrenia and healthy controls. In conclusion, Chinese AN-FEP patients were more prone to insulin resistance and dyslipidaemia as compared to the healthy population, which is negatively correlated to positive symptoms. The results may contribute to the understanding of the relationship between the glucose/lipidaemia metabolic dysfunction and the psychopathology in patients with schizophrenia.</description><identifier>ISSN: 0165-1781</identifier><identifier>EISSN: 1872-7123</identifier><identifier>DOI: 10.1016/j.psychres.2013.08.056</identifier><identifier>PMID: 24113122</identifier><identifier>CODEN: PSRSDR</identifier><language>eng</language><publisher>Kidlington: Elsevier Ireland Ltd</publisher><subject>Adult ; Adult and adolescent clinical studies ; Antipsychotic Agents - therapeutic use ; Antipsychotic-naive first-episode psychosis schizophrenia ; Asian Continental Ancestry Group ; Biological and medical sciences ; Blood Glucose - metabolism ; Body Mass Index ; Case-Control Studies ; China - epidemiology ; Cholesterol - blood ; Cross-Sectional Studies ; Dyslipidaemia ; Dyslipidemias - ethnology ; Female ; Glucose - metabolism ; Glucose Tolerance Test ; Humans ; Insulin - metabolism ; Insulin resistance ; Insulin Resistance - ethnology ; Lipid Metabolism - drug effects ; Male ; Medical sciences ; Psychiatry ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology ; Psychopathology. Psychiatry ; Psychoses ; Psychotic Disorders - drug therapy ; Regression Analysis ; Schizophrenia ; Schizophrenia - blood ; Schizophrenia - ethnology ; Schizophrenia - pathology ; Young Adult</subject><ispartof>Psychiatry research, 2013-12, Vol.210 (3), p.825-829</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2013 Elsevier Ireland Ltd</rights><rights>2015 INIST-CNRS</rights><rights>2013 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c453t-918da8a19a92edd8ddb4a0e9ecf6e8d625a2407d394e5d6e9b7533523d7d61f93</citedby><cites>FETCH-LOGICAL-c453t-918da8a19a92edd8ddb4a0e9ecf6e8d625a2407d394e5d6e9b7533523d7d61f93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0165178113005179$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28028090$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24113122$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Song</creatorcontrib><creatorcontrib>Broqueres-You, Dong</creatorcontrib><creatorcontrib>Yang, Guigang</creatorcontrib><creatorcontrib>Wang, Zhiren</creatorcontrib><creatorcontrib>Li, Yanli</creatorcontrib><creatorcontrib>Wang, Ning</creatorcontrib><creatorcontrib>Zhang, Xiangyang</creatorcontrib><creatorcontrib>Yang, Fude</creatorcontrib><creatorcontrib>Tan, Yunlong</creatorcontrib><title>Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia</title><title>Psychiatry research</title><addtitle>Psychiatry Res</addtitle><description>Abstract Controversial results concerning insulin resistance and lipid metabolism have been reported in antipsychotic-naive first-episode psychosis (AN-FEP) patients with schizophrenia of different countries. We aimed at determining whether schizophrenia-related psychopathology was associated with insulin resistance and/or dyslipidaemia in Chinese patients with AN-FEP schizophrenia. A cross-sectional study was performed in Chinese patients newly diagnosed with schizophrenia ( n = 49, antipsychotic-naïve or antipsychotic medications&lt; 2 weeks) and healthy volunteers ( n = 30). The serum levels of insulin and triglyceride levels as well as homeostasis model of assessment-insulin resistance (HOMA-IR) index were significantly increased in AN-FEP patients, when compared with healthy volunteers. The gender difference had a significant impact on the insulin resistance and dyslipidaemia in these AN-FEP subjects. Multiple linear regression analysis demonstrated that the severity of positive symptoms of schizophrenia was negatively related to insulin resistance. No difference of serum glucose level, total cholesterol content, body mass index (BMI) and smoking status was detected between patients with schizophrenia and healthy controls. In conclusion, Chinese AN-FEP patients were more prone to insulin resistance and dyslipidaemia as compared to the healthy population, which is negatively correlated to positive symptoms. The results may contribute to the understanding of the relationship between the glucose/lipidaemia metabolic dysfunction and the psychopathology in patients with schizophrenia.</description><subject>Adult</subject><subject>Adult and adolescent clinical studies</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Antipsychotic-naive first-episode psychosis schizophrenia</subject><subject>Asian Continental Ancestry Group</subject><subject>Biological and medical sciences</subject><subject>Blood Glucose - metabolism</subject><subject>Body Mass Index</subject><subject>Case-Control Studies</subject><subject>China - epidemiology</subject><subject>Cholesterol - blood</subject><subject>Cross-Sectional Studies</subject><subject>Dyslipidaemia</subject><subject>Dyslipidemias - ethnology</subject><subject>Female</subject><subject>Glucose - metabolism</subject><subject>Glucose Tolerance Test</subject><subject>Humans</subject><subject>Insulin - metabolism</subject><subject>Insulin resistance</subject><subject>Insulin Resistance - ethnology</subject><subject>Lipid Metabolism - drug effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Psychiatry</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Psychotic Disorders - drug therapy</subject><subject>Regression Analysis</subject><subject>Schizophrenia</subject><subject>Schizophrenia - blood</subject><subject>Schizophrenia - ethnology</subject><subject>Schizophrenia - pathology</subject><subject>Young Adult</subject><issn>0165-1781</issn><issn>1872-7123</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFktuKFDEQhhtR3HH1FZbcCF7YYw59yo0ogydYEDxch0xSzdTYnbRdmV3a5_CBzTizCt4IgQTqq0P-v4riSvC14KJ5sV9PtLjdDLSWXKg179a8bu4VK9G1smyFVPeLVQbrUrSduCgeEe0551Jo_bC4kJUQSki5Kn5-gsEmjIF2OLEtpFuAwDDQYcDAcnmkZIOD58wvNOCE3sKIltng2RQJE94Ao2WcUhxzGtvsMABBjif8PWFM6Mpgj1iPM6USJqTogU25LYRE7BbTjpHb4Y845Q8FtI-LB70dCJ6c78vi69s3Xzbvy-uP7z5sXl-XrqpVKrXovO2s0FZL8L7zfltZDhpc30DnG1lbWfHWK11B7RvQ27ZWqpbKt74RvVaXxbNT3WmO3w9AyYxIDobBBogHMqJqRNcJzlVGmxPq5kg0Q2-mGUc7L0Zwc3TE7M2dI-boiOGdyY7kxKtzj8N2BP8n7c6CDDw9A5acHfo5y430l-t4Pppn7tWJg6zIDcJsyGUBHXicwSXjI_5_lpf_lHDZZcxdv8ECtI-HOWS9jTAkDTefj_tzXB-hOM8PrX4B1wjHXg</recordid><startdate>20131230</startdate><enddate>20131230</enddate><creator>Chen, Song</creator><creator>Broqueres-You, Dong</creator><creator>Yang, Guigang</creator><creator>Wang, Zhiren</creator><creator>Li, Yanli</creator><creator>Wang, Ning</creator><creator>Zhang, Xiangyang</creator><creator>Yang, Fude</creator><creator>Tan, Yunlong</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131230</creationdate><title>Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia</title><author>Chen, Song ; Broqueres-You, Dong ; Yang, Guigang ; Wang, Zhiren ; Li, Yanli ; Wang, Ning ; Zhang, Xiangyang ; Yang, Fude ; Tan, Yunlong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c453t-918da8a19a92edd8ddb4a0e9ecf6e8d625a2407d394e5d6e9b7533523d7d61f93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Adult and adolescent clinical studies</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Antipsychotic-naive first-episode psychosis schizophrenia</topic><topic>Asian Continental Ancestry Group</topic><topic>Biological and medical sciences</topic><topic>Blood Glucose - metabolism</topic><topic>Body Mass Index</topic><topic>Case-Control Studies</topic><topic>China - epidemiology</topic><topic>Cholesterol - blood</topic><topic>Cross-Sectional Studies</topic><topic>Dyslipidaemia</topic><topic>Dyslipidemias - ethnology</topic><topic>Female</topic><topic>Glucose - metabolism</topic><topic>Glucose Tolerance Test</topic><topic>Humans</topic><topic>Insulin - metabolism</topic><topic>Insulin resistance</topic><topic>Insulin Resistance - ethnology</topic><topic>Lipid Metabolism - drug effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Psychiatry</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Psychotic Disorders - drug therapy</topic><topic>Regression Analysis</topic><topic>Schizophrenia</topic><topic>Schizophrenia - blood</topic><topic>Schizophrenia - ethnology</topic><topic>Schizophrenia - pathology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Song</creatorcontrib><creatorcontrib>Broqueres-You, Dong</creatorcontrib><creatorcontrib>Yang, Guigang</creatorcontrib><creatorcontrib>Wang, Zhiren</creatorcontrib><creatorcontrib>Li, Yanli</creatorcontrib><creatorcontrib>Wang, Ning</creatorcontrib><creatorcontrib>Zhang, Xiangyang</creatorcontrib><creatorcontrib>Yang, Fude</creatorcontrib><creatorcontrib>Tan, Yunlong</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Psychiatry research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Song</au><au>Broqueres-You, Dong</au><au>Yang, Guigang</au><au>Wang, Zhiren</au><au>Li, Yanli</au><au>Wang, Ning</au><au>Zhang, Xiangyang</au><au>Yang, Fude</au><au>Tan, Yunlong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia</atitle><jtitle>Psychiatry research</jtitle><addtitle>Psychiatry Res</addtitle><date>2013-12-30</date><risdate>2013</risdate><volume>210</volume><issue>3</issue><spage>825</spage><epage>829</epage><pages>825-829</pages><issn>0165-1781</issn><eissn>1872-7123</eissn><coden>PSRSDR</coden><abstract>Abstract Controversial results concerning insulin resistance and lipid metabolism have been reported in antipsychotic-naive first-episode psychosis (AN-FEP) patients with schizophrenia of different countries. We aimed at determining whether schizophrenia-related psychopathology was associated with insulin resistance and/or dyslipidaemia in Chinese patients with AN-FEP schizophrenia. A cross-sectional study was performed in Chinese patients newly diagnosed with schizophrenia ( n = 49, antipsychotic-naïve or antipsychotic medications&lt; 2 weeks) and healthy volunteers ( n = 30). The serum levels of insulin and triglyceride levels as well as homeostasis model of assessment-insulin resistance (HOMA-IR) index were significantly increased in AN-FEP patients, when compared with healthy volunteers. The gender difference had a significant impact on the insulin resistance and dyslipidaemia in these AN-FEP subjects. Multiple linear regression analysis demonstrated that the severity of positive symptoms of schizophrenia was negatively related to insulin resistance. No difference of serum glucose level, total cholesterol content, body mass index (BMI) and smoking status was detected between patients with schizophrenia and healthy controls. In conclusion, Chinese AN-FEP patients were more prone to insulin resistance and dyslipidaemia as compared to the healthy population, which is negatively correlated to positive symptoms. The results may contribute to the understanding of the relationship between the glucose/lipidaemia metabolic dysfunction and the psychopathology in patients with schizophrenia.</abstract><cop>Kidlington</cop><pub>Elsevier Ireland Ltd</pub><pmid>24113122</pmid><doi>10.1016/j.psychres.2013.08.056</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0165-1781
ispartof Psychiatry research, 2013-12, Vol.210 (3), p.825-829
issn 0165-1781
1872-7123
language eng
recordid cdi_proquest_miscellaneous_1461881003
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adult
Adult and adolescent clinical studies
Antipsychotic Agents - therapeutic use
Antipsychotic-naive first-episode psychosis schizophrenia
Asian Continental Ancestry Group
Biological and medical sciences
Blood Glucose - metabolism
Body Mass Index
Case-Control Studies
China - epidemiology
Cholesterol - blood
Cross-Sectional Studies
Dyslipidaemia
Dyslipidemias - ethnology
Female
Glucose - metabolism
Glucose Tolerance Test
Humans
Insulin - metabolism
Insulin resistance
Insulin Resistance - ethnology
Lipid Metabolism - drug effects
Male
Medical sciences
Psychiatry
Psychology. Psychoanalysis. Psychiatry
Psychopathology
Psychopathology. Psychiatry
Psychoses
Psychotic Disorders - drug therapy
Regression Analysis
Schizophrenia
Schizophrenia - blood
Schizophrenia - ethnology
Schizophrenia - pathology
Young Adult
title Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T18%3A54%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationship%20between%20insulin%20resistance,%20dyslipidaemia%20and%20positive%20symptom%20in%20Chinese%20antipsychotic-naive%20first-episode%20patients%20with%20schizophrenia&rft.jtitle=Psychiatry%20research&rft.au=Chen,%20Song&rft.date=2013-12-30&rft.volume=210&rft.issue=3&rft.spage=825&rft.epage=829&rft.pages=825-829&rft.issn=0165-1781&rft.eissn=1872-7123&rft.coden=PSRSDR&rft_id=info:doi/10.1016/j.psychres.2013.08.056&rft_dat=%3Cproquest_cross%3E1461881003%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1461881003&rft_id=info:pmid/24113122&rft_els_id=1_s2_0_S0165178113005179&rfr_iscdi=true